Director, Launch Preparedness, Policy & Advocacy Strategy, and Execution Lead, MD

ROLE SUMMARY

The Launch Preparedness Policy & Advocacy Strategy and Execution Lead is a leadership role within the U.S. Vaccines Field Medical organization accountable for launch preparedness policy integration advocacy strategy and field medical readiness across priority vaccine and drug assets.

Reporting to the Vaccines National Accounts Organized & Retail Customer Policy Lead this role provides seniorlevel leadership for U.S. launch readiness and execution ensuring that policy access coverage and advocacy considerations are proactively anticipated and effectively integrated into field medical strategy enablement and deployment across the Vaccines portfolio. The role operates at individual contributor level with an initial focus on the Lyme Vaccine (LB6V) and responsibility to support additional vaccine and drug launches as portfolio priorities evolve.

This role partners closely with Vaccines HQ Medical Scientific Engagement Leads (SELs) Commercial leadership Medical Analytics Medical Engagement & Impact (MEI) National Accounts leadership and external medical societies to ensure coordinated policyinformed and fieldready execution that supports successful launches and sustained adoption.

Serving as a principal strategic advisor to Vaccines Field Medical leadership U.S. Medical Affairs Vaccines Policy and crossfunctional partners this role acts as a critical connector between HQ strategy and field medical execution. It plays a central leadership role in shaping launch readiness expectations field engagement approaches and medical execution models with a strong emphasis on anticipating policy coverage and advocacy dynamics to enable effective launch preparation and sustained impact across the U.S. Vaccines portfolio.

ROLE RESPONSIBILITIES

Launch Preparedness & Execution

***(Initial Focus: Lyme Vaccine LB6V; Broader Portfolio Scope)

• Set and govern national launch preparedness strategy and operating standards for priority U.S. vaccine and drug launches with an initial focus on the Lyme Vaccine (LB6V) and flexibility to support additional assets as portfolio priorities evolve.

• Define maintain and govern enterprisewide launch readiness standards success metrics and policyrelated readiness expectations for Vaccines Field Medical ensuring consistent application across assets and field teams.

• Serve as the escalation authority for policydriven risks and access barriers that may impact launch timing uptake or sustainability providing strategic recommendations and decision support to U.S. Medical Affairs and Commercial leadership.

• Partner with HQ Brand Medical leads and crossfunctional stakeholders including Commercial Operations Medical Analytics and Vaccines Field Medical leadership to anticipate and shape national field deployment models engagement priorities and enablement strategies without duplicating assetlevel strategy ownership.

• Provide enterprise oversight and strategic direction for PreApproval Information Exchange (PIE) readiness and execution ensuring consistent governance insight synthesis and readiness expectations across launches.

• Leverage enterpriselevel medical insights analytics and engagement data to continuously refine launch preparedness frameworks and optimize field medical effectiveness at scale.

• Provide strategic oversight and direction for the development and deployment of launchrelated training playbooks and field readiness materials ensuring alignment with enterprise standards and policyinformed engagement expectations.

• Ensure scalable repeatable and policyintegrated launch preparedness approaches are applied across pipeline and inline assets rather than assetspecific or ad hoc execution models.

Policy Strategy & Advocacy Execution

• Serve as the Field Medical Policy Lead for U.S. Vaccines with enterprise accountability for how field medical policy and advocacy engagement is operationalized in close alignment with but distinct from the U.S. Medical Affairs Vaccines Policy team which retains ownership of policy development.

• Set national strategic direction for field medical policy and advocacy engagement models that support launch readiness lifecycle management and access outcomes across the Vaccines portfolio.

• Provide enterpriselevel oversight and guidance for field medical engagement with key medical societies that influence vaccine recommendations clinical guidelines and access ensuring consistent national standards rather than individual asset approaches.

• Lead and shape enterprise field medical engagement across national organizations including ACOG AAP IDSA ACP AAFP and other relevant professional societies governing engagement frameworks rather than executing all interactions directly.

• Apply deep expertise in ACIP processes medical society governance payer coverage dynamics and statelevel regulatory environments to proactively identify policydriven risks and opportunities requiring enterprise coordination or escalation.

• Translate policy guideline and coverage developments into clear compliant and standardized field medical engagement expectations supporting appropriate utilization access and population health outcomes.

• Represent Vaccines Field Medical in enterprise policy forums crossfunctional governance bodies and leadership discussions ensuring Field Medical perspectives inform decisionmaking without duplicating policy ownership.

CrossFunctional Partnership & Field Enablement

• Act as a strategic bridge between HQ and Field Medical teams ensuring bidirectional communication enterprise alignment and executional clarity related to launch policy and advocacy strategy.

• Influence Scientific Engagement Leads Field Medical society leads and Field Medical stakeholders through subjectmatter expertise strategic guidance and escalation authority rather than formal people leadership.

• Establish and reinforce enterprise standards and guidance for policyrelated field medical messaging and engagement approaches ensuring consistency and confidence across teams and assets.

• Incorporate field feedback external insights and evolving policy dynamics to continuously refine enterprise launch preparedness and advocacy execution frameworks.

BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers develop and coach others oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

• MD/DO degree required and 5 years of relevant experience

• Demonstrated success operating with enterprise or national accountability and influencing outcomes across highly matrixed organizations.

• Deep expertise in U.S. vaccine policy ACIP processes medical society engagement and payer and coverage landscapes.

• Proven ability to lead complex highvisibility and policysensitive initiatives through influence and governance without direct people management responsibility.

• Experience serving as a strategic advisor to senior and executive leadership including VPlevel stakeholders.

• Strong strategic mindset with the ability to operate effectively in ambiguity and translate complexity into clear enterprise direction and executional standards.

• Excellent written and verbal communication skills with demonstrated success engaging senior internal and external stakeholders.

PREFERRED QUALIFICATIONS

• Prior experience supporting U.S. vaccine or specialty product launches including preapproval readiness and crossfunctional field enablement.

• Experience working closely with or engaging U.S. medical societies guidelinesetting bodies or policyinfluencing organizations.

NON-STANDARD WORK SCHEDULE TRAVEL OR ENVIRONMENT REQUIREMENTS

• Ability to travel up to 40 percent including overnight travel.

Must comply with all Pfizer corporate travel policies and procedures.

OTHER JOB DETAILS

• Last Date to Apply for Job: July 20th 2026

• Eligible for Relocation Package: No

The annual base salary for this position ranges from $230900.00 to $384800.00. In addition this position is eligible for participation in Pfizers Global Performance Plan with a bonus target of 25.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of lifes moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution paid vacation holiday and personal days paid caregiver/parental and medical leave and health benefits to include medical prescription drug dental and vision coverage. Learn more at Pfizer Candidate Site U.S. Benefits (). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa FL or any location outside of the United States. This role is posted in multiple locations. If you are applying for the role in an secondary job posting location where pay transparency regulations apply your Talent Advisor will share the local pay information with you during the first interview.

Relocation assistance may be available based on business needs and/or eligibility.

Candidates must be authorized to be employed in the U.S. by any employer.

U.S. work visa sponsorship (such as TN O-1 H-1B etc.) is not available for this role now or in the future.

To learn more about acceptable and prohibited uses of AI during the recruitment process please review our candidate AI-use guidelines available onPfizer Careers.

Medical